TY - JOUR
T1 - Quality of life after endoscopic procedures for chronic pancreatitis
T2 - A multicentre study
AU - Parhiala, Mikael
AU - Nøjgaard, Camilla
AU - Bartholdy, Andreas
AU - Waage, Anne
AU - Ignatavičius, Povilas
AU - Engjom, Trond
AU - Dimcevski, Georg
AU - Nordaas, Ingrid Kvåle
AU - Kalaitzakis, Evangelos
AU - Drewes, Asbjørn M
AU - Hadi, Amer
AU - Olesen, Søren S
AU - Poulsen, Jakob L
AU - Laukkarinen, Johanna
AU - Scandinavian Baltic Pancreatic Club
N1 - © 2023 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology.
PY - 2023/11
Y1 - 2023/11
N2 - BACKGROUND: Chronic Pancreatitis (CP) causes morphological changes in the pancreatic tissue, leading to complications and pain, which may require endoscopic interventions.OBJECTIVE: Our aim was to determine the frequency of endoscopic procedures (EP) in CP patients and to analyse pain and quality of life (QoL) in these patients after their EP.METHODS: This study included 1327 CP patients from the Scandinavian Baltic Pancreatic Club (SBPC) database including four countries and eight centres. We analysed patients undergoing EPs and gathered information on the EP, pancreatic function, pain, disease and duration. The EORTC C-30 QoL questionnaire was gathered prospectively and multivariable analysis was conducted on independent parameters between the groups. The reference population had no interventions (n = 870).RESULTS: 260 CP patients (22%) underwent EPs, median one year (range 0-39 years) after CP diagnosis. 68% were males. The median age was 59 (20-90) years. Most common aetiological factors were alcohol in 65% and smoking in 71%. Extracorporeal shock wave lithotripsy (ESWL) was used in 6% of the CP population and in 21% of the EP group. Biliary duct stenting was performed on 37% and pancreatic stenting was performed on 56% of the patients. There was no difference in pain patterns between patients who had pancreatic stenting and the reference population. The EP group had slightly better QoL (p = 0.047), functioning and fewer symptoms than the reference population, in the multivariable analysis there was no interaction effect analysis between the groups. The pancreatic stent group had better QoL and the same amount of pain than the reference group. The patients who needed later surgery (23%) had more pain (p = 0.043) and fatigue (p = 0.021).CONCLUSIONS: One in five of the CP patients underwent EP. These patients scored higher on QoL responses and had better symptom scores. CP patients who had pancreatic stenting performed had the same pain patterns as the reference population. Randomised prospective trials are needed to determine the effect of endoscopy procedures on CP patients.
AB - BACKGROUND: Chronic Pancreatitis (CP) causes morphological changes in the pancreatic tissue, leading to complications and pain, which may require endoscopic interventions.OBJECTIVE: Our aim was to determine the frequency of endoscopic procedures (EP) in CP patients and to analyse pain and quality of life (QoL) in these patients after their EP.METHODS: This study included 1327 CP patients from the Scandinavian Baltic Pancreatic Club (SBPC) database including four countries and eight centres. We analysed patients undergoing EPs and gathered information on the EP, pancreatic function, pain, disease and duration. The EORTC C-30 QoL questionnaire was gathered prospectively and multivariable analysis was conducted on independent parameters between the groups. The reference population had no interventions (n = 870).RESULTS: 260 CP patients (22%) underwent EPs, median one year (range 0-39 years) after CP diagnosis. 68% were males. The median age was 59 (20-90) years. Most common aetiological factors were alcohol in 65% and smoking in 71%. Extracorporeal shock wave lithotripsy (ESWL) was used in 6% of the CP population and in 21% of the EP group. Biliary duct stenting was performed on 37% and pancreatic stenting was performed on 56% of the patients. There was no difference in pain patterns between patients who had pancreatic stenting and the reference population. The EP group had slightly better QoL (p = 0.047), functioning and fewer symptoms than the reference population, in the multivariable analysis there was no interaction effect analysis between the groups. The pancreatic stent group had better QoL and the same amount of pain than the reference group. The patients who needed later surgery (23%) had more pain (p = 0.043) and fatigue (p = 0.021).CONCLUSIONS: One in five of the CP patients underwent EP. These patients scored higher on QoL responses and had better symptom scores. CP patients who had pancreatic stenting performed had the same pain patterns as the reference population. Randomised prospective trials are needed to determine the effect of endoscopy procedures on CP patients.
KW - Endoscopy/adverse effects
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Pain/etiology
KW - Pancreatic Ducts/surgery
KW - Pancreatitis, Chronic/diagnosis
KW - Prospective Studies
KW - Quality of Life
KW - biliary stent
KW - chronic pancreatitis
KW - extracorporeal shock wave lithotripsy
KW - endoscopic retrograde cholangiopancreatography
KW - pancreatic stent
KW - quality of life
UR - http://www.scopus.com/inward/record.url?scp=85173923243&partnerID=8YFLogxK
U2 - 10.1002/ueg2.12466
DO - 10.1002/ueg2.12466
M3 - Journal article
C2 - 37812591
SN - 2050-6414
VL - 11
SP - 884
EP - 893
JO - United European Gastroenterology Journal
JF - United European Gastroenterology Journal
IS - 9
ER -